Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib on Endothelial Cells: A Potential Mechanism to Explain Vasculopathies in Cml Patients Treated With Nilotinib
Emir Hadzijusufovic(University of Veterinary Medicine Vienna), Peter Valent(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Gregor Hoermann(University of Freiburg), Wilfried Schgoer, Susanne Herndlhofer(Assistance Publique – Hôpitaux de Paris), Markus Theurl(Innsbruck Medical University), Sabine Cerny‐Reiterer(Medical University of Vienna), K. Huber(Austrian Academy of Sciences), Gregor Eisenwort(Ludwig Boltzmann Institute for Cardiovascular Research), Karin Albrecht-Schgoer(Innsbruck Medical University), Giulio Superti‐Furga(Austrian Academy of Sciences), Wolfgang R. Sperr(Medical University of Vienna), Bernd Jilma(Medical University of Vienna), Ghanim Ghanim, Irina Sadovnik(Medical University of Vienna), Rudolf Kirchmair(Innsbruck Medical University), Donna M. Cartledge Wolf, Florian Grebien(University of Veterinary Medicine Vienna), Christoph Kaun(University of Vienna), Uwe Rix(University of South Florida)
Unknown
January 1, 2014
Cited by 0
Related Papers
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589